Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial.

Add to Collection

2013 Dec Others JPH Wilding, G Charpentier, P Hollander… - … journal of clinical …, 2013 - Wiley Online Library 109

Full Author : ['Wilding, J P H', 'Charpentier, G', 'Hollander, P', 'Gonzalez-Galvez, G', 'Mathieu, C', 'Vercruysse, F', 'Usiskin, K', 'Law, G', 'Black, S', 'Canovatchel, W', 'Meininger, G']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2013
Cited by : 390.0

AIMS: Canagliflozin is a sodium glucose co-transporter 2 inhibitor developed for the treatment of type 2 diabetes mellitus (T2DM). This randomised, double-blind, placebo-controlled, Phase 3 study evaluated the efficacy and safety of canagliflozin as an ad..... Read More

Keywords : ["type diabetes mellitus inadequately control", "randomised trial", "sulphonylurea", "safety", "patient", "metformin", "efficacy", "canagliflozin"]
PubMed Link : https://onlinelibrary.wiley.com/doi/abs/10.1111/ijcp.12322
Google Scholar Link : https://scholar.google.com/scholar?cites=17494159792730851447&as_sdt=5,41&sciodt=0,41&hl=en&num=20

Have a Question?

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial.